Search

Kent Joseph Barbay

age ~50

from Flourtown, PA

Get Report
Also known as:
  • Kent J Barbay
  • Joseph Kent Barbay
  • Joseph K Barbay
  • Joseph E Barbay
  • Jospeh Barbay
  • Joe Barbay
  • Joseph Kent
  • Joseph Y
Phone and address:
6311 Sunnybrook Rd, Flourtown, PA 19031
Connected to:

Kent Barbay Phones & Addresses

  • 6311 Sunnybrook Rd, Flourtown, PA 19031
  • Ocala, FL
  • Port Saint Joe, FL
  • 129 Rue Charmille Rd, Ft Washington, PA 19034 • 215 283-0334
  • Fort Washington, PA
  • Murphysboro, IL
  • Cambridge, MA
  • Pasadena, CA
  • Champaign, IL
  • Saint Louis, MO
  • Montgomery, PA
  • 129 Rue Charmille Rd #A, Ft Washington, PA 19034

Work

  • Company:
    Johnson & johnson
  • Position:
    Scientist

Education

  • Degree:
    Doctorates, Doctor of Philosophy
  • School / High School:
    Harvard University
    1996 to 2002
  • Specialities:
    Organic Chemistry

Industries

Pharmaceuticals

Us Patents

  • Pyridazinone Ureas As Antagonists Of Alpha4 Integrins

    view source
  • US Patent:
    20050209232, Sep 22, 2005
  • Filed:
    Feb 9, 2005
  • Appl. No.:
    11/054175
  • Inventors:
    Kent Barbay - Flourtown PA, US
    Yong Gong - Warrington PA, US
    Wei He - Audubon PA, US
  • International Classification:
    A61K031/5377
    A61K031/501
    C07D413/02
    C07D043/02
  • US Classification:
    514235500, 514247000, 514252030, 514252050, 514252060, 544113000, 544238000, 544239000
  • Abstract:
    The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating α4 integrin mediated disorders. More particularly, the pyridazinone urea compounds of the present invention are α4β7 integrin inhibitors useful for treating integrin mediated disorders.

  • Pyridazinones As Antagonists Of Alpha4 Integrins

    view source
  • US Patent:
    20050192279, Sep 1, 2005
  • Filed:
    Feb 9, 2005
  • Appl. No.:
    11/054190
  • Inventors:
    Kent Barbay - Flourtown PA, US
    Alexey Dyatkin - Maple Glen PA, US
    Yong Gong - Warrington PA, US
    Wei He - Audubon PA, US
    Tamara Miskowski - Chalfont PA, US
  • International Classification:
    C07D043/02
    A61K031/501
    A61K031/50
  • US Classification:
    514247000, 514252030, 514252050, 544238000, 544239000
  • Abstract:
    The present invention relates to certain novel compounds of Formula (I): methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of integrin mediated disorders.

  • Alkyl Linked Quinolinyl Modulators Of Rorγt

    view source
  • US Patent:
    20170258782, Sep 14, 2017
  • Filed:
    Mar 14, 2016
  • Appl. No.:
    15/069030
  • Inventors:
    - Beerse, BE
    Kent Barbay - Flourtown PA, US
    James P. Edwards - San Diego CA, US
    Kevin D. Kreutter - Plainsboro NJ, US
    David A. Kummer - San Diego CA, US
    Umar Maharoof - North Wales PA, US
    Rachel Nishimura - San Diego CA, US
    Maud Urbanski - Flemington NJ, US
    Hariharan Venkatesan - San Diego CA, US
    Aihua Wang - Jamison PA, US
    Ronald L. Wolin - San Diego CA, US
    Craig R. Woods - San Diego CA, US
    Anne Fourie - San Diego CA, US
    Xiaohua Xue - San Diego CA, US
    Maxwell D. Cummings - Ambler PA, US
  • International Classification:
    A61K 31/4709
  • Abstract:
    The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

  • Phenyl Linked Quinolinyl Modulators Of Rorgammat

    view source
  • US Patent:
    20160279122, Sep 29, 2016
  • Filed:
    Jun 14, 2016
  • Appl. No.:
    15/182231
  • Inventors:
    - Beerse, BE
    Kent Barbay - Flourtown PA, US
    James P. Edwards - San Diego CA, US
    Kevin D. Kreutter - Plainsboro NJ, US
    David A. Kummer - San Diego CA, US
    Umar Maharoof - North Wales PA, US
    Rachel Nishimura - San Diego CA, US
    Maud Urbanski - Flemington NJ, US
    Hariharan Venkatesan - San Diego CA, US
    Aihua Wang - Jamison PA, US
    Ronald L. Wolin - San Diego CA, US
    Craig R. Woods - San Diego CA, US
    Anne Fourie - San Diego CA, US
    Xiaohua Xue - San Diego CA, US
    Maxwell D. Cummings - Ambler PA, US
  • International Classification:
    A61K 31/4709
    A61K 45/06
    A61K 31/506
  • Abstract:
    The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

  • Heteroaryl Linked Quinolinyl Modulators Of Roryt

    view source
  • US Patent:
    20160136149, May 19, 2016
  • Filed:
    Jan 22, 2016
  • Appl. No.:
    15/004048
  • Inventors:
    - Beerse, BE
    Kent Barbay - Flourtown PA, US
    James P. Edwards - San Diego CA, US
    Kevin D. Kreutter - Plainsboro NJ, US
    David A. Kummer - San Diego CA, US
    Umar Maharoof - North Wales PA, US
    Rachel Nishimura - San Diego CA, US
    Maud Urbanski - Flemington NJ, US
    Hariharan Venkatesan - San Diego CA, US
    Aihua Wang - Jamison PA, US
    Ronald L. Wolin - San Diego CA, US
    Craig R. Woods - San Diego CA, US
    Anne Fourie - San Diego CA, US
    Xiaohua Xue - San Diego CA, US
    Maxwell D. Cummings - Ambler PA, US
  • Assignee:
    Janssen Pharmaceutica NV - New Brunswick NJ
  • International Classification:
    A61K 31/4709
    A61K 45/06
  • Abstract:
    The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, RR, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

  • Heteroaryl Linked Quinolinyl Modulators Of Rorgammat

    view source
  • US Patent:
    20150105365, Apr 16, 2015
  • Filed:
    Oct 15, 2013
  • Appl. No.:
    14/053736
  • Inventors:
    - Beerse, BE
    Kent Barbay - Flourtown PA, US
    James P. Edwards - San Diego CA, US
    Kevin D. Kreutter - Plainsboro NJ, US
    David A. Kummer - San Diego CA, US
    Umar Maharoof - North Wales PA, US
    Rachel Nishimura - San Diego CA, US
    Maud Urbanski - Flemington NJ, US
    Hariharan Venkatesan - San Diego CA, US
    Aihua Wang - Jamison PA, US
    Ronald L. Wolin - San Diego CA, US
    Craig R. Woods - San Diego CA, US
    Anne Fourie - San Diego CA, US
    Xiaohua Xue - San Diego CA, US
    Maxwell D. Cummings - Ambler PA, US
  • Assignee:
    Janssen Pharmaceutica NV - Beerse
  • International Classification:
    C07D 401/14
    C07D 401/12
    A61K 45/06
    A61K 31/4709
  • US Classification:
    51421002, 51421021, 514312, 540362, 546153
  • Abstract:
    The present invention comprises compounds of Formula I.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

  • Methylene Linked Quinolinyl Modulators Of Roryt

    view source
  • US Patent:
    20150105366, Apr 16, 2015
  • Filed:
    Oct 15, 2013
  • Appl. No.:
    14/053797
  • Inventors:
    - Beerse, BE
    Kent Barbay - Flourtown PA, US
    James P. Edwards - San Diego CA, US
    Kevin D. Kreutter - Plainsboro NJ, US
    David A. Kummer - San Diego CA, US
    Umar Maharoof - North Wales PA, US
    Rachel Nishimura - San Diego CA, US
    Maud Urbanski - Flemington NJ, US
    Hariharan Venkatesan - San Diego CA, US
    Aihua Wang - Jamison PA, US
    Ronald L. Wolin - San Diego CA, US
    Craig R. Woods - San Diego CA, US
    Anne Fourie - San Diego CA, US
    Xiaohua Xue - San Diego CA, US
    Maxwell D. Cummings - Ambler PA, US
    William Moore Jones - San Diego CA, US
    Steven Goldberg - Encinitas CA, US
  • Assignee:
    Janssen Pharmaceutica NV - Beerse
  • International Classification:
    C07D 417/14
    A61K 31/4709
    A61K 45/06
    C07D 413/14
    C07D 409/14
    C07D 401/06
    A61K 31/506
    A61K 31/5377
    C07D 405/14
    C07D 401/14
  • US Classification:
    51421018, 546157, 514312, 546176, 514314, 546175, 546172, 544333, 514256, 51421021, 546153, 546159, 514313, 544128, 5142352
  • Abstract:
    The present invention comprises compounds of Formula I.wherein:The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

  • Alkyl Linked Quinolinyl Modulators Of Roryt

    view source
  • US Patent:
    20150105369, Apr 16, 2015
  • Filed:
    Oct 14, 2014
  • Appl. No.:
    14/513455
  • Inventors:
    - BEERSE, BE
    KENT BARBAY - FLOURTOWN PA, US
    JAMES P. EDWARDS - SAN DIEGO CA, US
    KEVIN D. KREUTTER - PLAINSBORO NJ, US
    DAVID A. KUMMER - SAN DIEGO CA, US
    UMAR MAHAROOF - NORTH WALES PA, US
    RACHEL NISHIMURA - SAN DIEGO CA, US
    MAUD URBANSKI - FLEMINGTON NJ, US
    HARIHARAN VENKATESAN - SAN DIEGO CA, US
    AIHUA WANG - JAMISON PA, US
    RONALD L. WOLIN - SAN DIEGO CA, US
    CRAIG R. WOODS - SAN DIEGO CA, US
    ANNE FOURIE - SAN DIEGO CA, US
    XIAOHUA XUE - SAN DIEGO CA, US
    MAXWELL D. CUMMINGS - AMBLER PA, US
  • International Classification:
    C07D 401/06
    C07D 417/06
    C07D 413/06
  • US Classification:
    51421018, 546173, 514314, 546172, 546157, 514312, 51421021
  • Abstract:
    The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

Resumes

Kent Barbay Photo 1

Scientist

view source
Location:
Flourtown, PA
Industry:
Pharmaceuticals
Work:
Johnson & Johnson
Scientist
Education:
Harvard University 1996 - 2002
Doctorates, Doctor of Philosophy, Organic Chemistry
Get Report for Kent Joseph Barbay from Flourtown, PA, age ~50
Control profile